DK37888A - Cannabinolderivat - Google Patents

Cannabinolderivat

Info

Publication number
DK37888A
DK37888A DK037888A DK37888A DK37888A DK 37888 A DK37888 A DK 37888A DK 037888 A DK037888 A DK 037888A DK 37888 A DK37888 A DK 37888A DK 37888 A DK37888 A DK 37888A
Authority
DK
Denmark
Prior art keywords
derivative
group
cannabinol
aminoalkyl group
derivatives
Prior art date
Application number
DK037888A
Other languages
English (en)
Other versions
DK37888D0 (da
Inventor
Alan Joseph Mcnally
Alan Schwartz
Magdalena Usategui
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK37888D0 publication Critical patent/DK37888D0/da
Publication of DK37888A publication Critical patent/DK37888A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK037888A 1987-01-27 1988-01-26 Cannabinolderivat DK37888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/007,838 US4833073A (en) 1987-01-27 1987-01-27 Immunoassay for tetrahydrocannabinol metabolites

Publications (2)

Publication Number Publication Date
DK37888D0 DK37888D0 (da) 1988-01-26
DK37888A true DK37888A (da) 1988-07-28

Family

ID=21728380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK037888A DK37888A (da) 1987-01-27 1988-01-26 Cannabinolderivat

Country Status (12)

Country Link
US (1) US4833073A (da)
EP (1) EP0276732B1 (da)
JP (1) JPH0819117B2 (da)
AT (1) ATE97895T1 (da)
AU (1) AU614733B2 (da)
DE (1) DE3885911T2 (da)
DK (1) DK37888A (da)
ES (1) ES2060610T3 (da)
FI (1) FI96685C (da)
HK (1) HK63595A (da)
NO (1) NO171274C (da)
NZ (1) NZ223289A (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264373A (en) * 1987-02-17 1993-11-23 Abbott Laboratories Fluorescence polarization immunoassay for tetrahydrocannabinoids
EP0392332A3 (de) * 1989-04-12 1992-01-08 F. Hoffmann-La Roche Ag Fluoreszenzpolarisationsimmunoassay und Reagentien dafür
US5001743A (en) * 1990-01-10 1991-03-19 Northern Telecom Limited Method and apparatus for controlling a telephone answering device
IL99468A (en) * 1991-09-12 1997-09-30 Yissum Res Dev Co (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
US5292899A (en) * 1991-11-27 1994-03-08 Synthetic Technology Corporation Synthesis of 11-nor-Δ-9-tetrahydrocannabinol-9-carboxylic acid glucuronide
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5315015A (en) * 1992-11-10 1994-05-24 Hoffmann-La Roche Inc. Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same
US5817766A (en) * 1995-04-05 1998-10-06 Roche Diagnostic Systems, Inc. Reagents for a cannabinoid immunoassay
US6162829A (en) * 1997-10-17 2000-12-19 Atlantic Pharmaceuticals, Inc. (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US6248598B1 (en) 1998-09-17 2001-06-19 Stuart C. Bogema Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
AU3910700A (en) 1999-03-22 2000-10-09 Immugen Pharmaceuticals, Inc. Treatment of immune diseases
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US8084467B2 (en) 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7741365B2 (en) 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US7393842B2 (en) 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
CA2387764A1 (en) 1999-10-18 2001-04-26 University Of Connecticut Peripheral cannabinoid receptor (cb2) selective ligands
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
EP1361876A4 (en) 2001-01-26 2004-03-31 Univ Connecticut NEW CANNABIMIMETIC LIGANDS
DE60237431D1 (de) 2001-01-29 2010-10-07 Univ Connecticut Rezeptor-selektive cannabimimetische aminoalkylindole
JP4312594B2 (ja) 2001-07-13 2009-08-12 ユニバーシティ オブ コネチカット 新規な二環式及び三環式カンナビノイド
US7666867B2 (en) 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
WO2003080043A1 (en) * 2002-03-18 2003-10-02 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2003265663A1 (en) * 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
US8288544B2 (en) 2003-07-01 2012-10-16 Roche Diagnostics Operations, Inc. Electrochemical affinity biosensor system and methods
US20060051824A1 (en) * 2004-09-03 2006-03-09 Haoyun An Tetrahydrocannabinoid antigens and method of use
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
US10458963B2 (en) 2016-06-08 2019-10-29 Kathleen Stitzlein Quantitative HPTLC cannabinoid field testing device and method
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
EP4089081B1 (en) * 2020-01-08 2025-07-23 Chengdu Baiyu Pharmaceutical Co., Ltd. Tetrahydrocannabinol derivative, and preparation method therefor and medical use thereof
WO2021139739A1 (zh) 2020-01-08 2021-07-15 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
CN119534358A (zh) * 2023-08-28 2025-02-28 广州达安基因股份有限公司 Δ9-四氢大麻酚的检测试剂及其制备方法和检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
IL39323A (en) * 1971-05-14 1975-08-31 Syva Co Highly sensitive assay method employing an enzyme for amplification
US4438207A (en) * 1979-09-26 1984-03-20 Hoffmann-La Roche Inc. Radioimmunoassay for cannabinoids
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4652681A (en) * 1982-04-15 1987-03-24 Drug Science Foundation Aminoalkoxy derivatives of propranolol for immunoassay applications
US4650771A (en) * 1983-11-04 1987-03-17 Miles Laboratories, Inc. Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof

Also Published As

Publication number Publication date
AU614733B2 (en) 1991-09-12
DE3885911T2 (de) 1994-03-24
ATE97895T1 (de) 1993-12-15
FI880332A7 (fi) 1988-07-28
DK37888D0 (da) 1988-01-26
JPS63192770A (ja) 1988-08-10
AU1111588A (en) 1988-07-28
HK63595A (en) 1995-05-05
FI96685C (fi) 1996-08-12
NO171274C (no) 1993-02-17
ES2060610T3 (es) 1994-12-01
EP0276732B1 (en) 1993-12-01
JPH0819117B2 (ja) 1996-02-28
FI880332A0 (fi) 1988-01-26
NO880330D0 (no) 1988-01-26
FI96685B (fi) 1996-04-30
EP0276732A3 (en) 1989-02-22
DE3885911D1 (de) 1994-01-13
NZ223289A (en) 1989-06-28
EP0276732A2 (en) 1988-08-03
NO880330L (no) 1988-07-28
NO171274B (no) 1992-11-09
US4833073A (en) 1989-05-23

Similar Documents

Publication Publication Date Title
NO880330D0 (no) Cannabinolderivater.
DE3880383D1 (de) Vernetzungsmittel zur haarbehandlung.
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
KR950701640A (ko) 에리트로마이신 유도체(eryhromycin derivative)
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
ATE194339T1 (de) Verbesserte immunoessayreagenzien zum nachweis von kannabinoiden
ATE227710T1 (de) Oxazole derivate,ihre herstellung und verwendung
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
NO890689L (no) Spesielle kjemiluminiscerende akridinderivater og deres anvendelse i luminiscens-immunoanalyser.
ATE72831T1 (de) Konjugate von glucose-6-phosphat-dehydrogenase, ihre herstellung und verwendung.
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
ES2046229T3 (es) Composicion antiulcerosa.
DE3675778D1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
DK21287A (da) Penemderivater
DE68905406D1 (de) Chinolin-verbindung.
DE3767527D1 (de) Derivate vom benzoquinonylphenylalkansaeure-amid.
SE8506015D0 (sv) Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
DE3677857D1 (de) 2,5-dimethylpyrrolderivative, ihre herstellung und ihre verwendung.
KR890008151A (ko) 키놀린 카르복산의 유도체
ES2018874B3 (es) Derivado taurine, su preparacion y composiciones farmaceuticas que lo contiene
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
DE3861545D1 (de) Aminoverbindungen und diese enthaltende fungizide.
KR890002190A (ko) 퀴놀린 카르본산 유도체
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment